GlaxoSmithKline Exits US Penicillin Biz, Sells Plants to Dr. Reddy’s Laboratories Ltd.

Pharmaceutical Business Review -- GlaxoSmithKline and Dr Reddy’s Laboratories have signed an agreement relating to GSK’s US oral penicillin facility and product portfolio.

MORE ON THIS TOPIC